HORIZON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Horizon Therapeutics Public Limited Company - HZNPBusiness Wire • 12/14/22
BLINCYTO® (BLINATUMOMAB) ADDED TO CONSOLIDATION CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN ADULT PATIENTS WITH MEASURABLE RESIDUAL DISEASE-NEGATIVE B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)PRNewsWire • 12/13/22
SHAREHOLDER ALERT: Weiss Law Investigates Horizon Therapeutics Public Limited CompanyPRNewsWire • 12/12/22
Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing ContinuesInvestors Business Daily • 12/12/22
Amgen wins battle for Horizon Therapeutics, bolstering its rare-disease portfolioMarket Watch • 12/12/22
Billionaire John Paulson is reportedly set to reap $500 million from Amgen's huge deal to acquire Horizon TherapeuticsBusiness Insider • 12/12/22